Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Karyopharm Therapeutics
KPTI
$45.1M
| $17.1M | 0.02% |
84,818
+55,696
| +191% | +$11.1M |
|
|
SRC
977
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $17.1M | 0.02% |
490,205
-454,828
| -48% | -$16.2M |
|
|
CSGS
978
DELISTED
CSG Systems International
CSGS
| $16.9M | 0.02% |
374,227
+17,188
| +5% | +$788K |
|
|
FINL
979
DELISTED
Finish Line
FINL
| $16.9M | 0.02% |
1,251,109
+1,065,195
| +573% | +$12.3M |
|
980
American Financial Group
AFG
$11.8B
| $16.9M | 0.02% |
150,859
+129,538
| +608% | +$14.5M |
|
981
CytomX Therapeutics
CTMX
$686M
| $16.9M | 0.02% |
594,788
-242,627
| -29% | -$6.92M |
|
|
BZUN
982
Baozun
BZUN
$176M
| $16.9M | 0.02% |
+367,978
| New | +$14.5M |
|
983
Columbia Sportswear
COLM
$2.99B
| $16.9M | 0.02% |
220,618
+171,098
| +346% | +$12.9M |
|
984
Globus Medical
GMED
$11B
| $16.9M | 0.02% |
338,418
+48,022
| +17% | +$2.26M |
|
|
BAS
985
DELISTED
Basis Energy Services, Inc.
BAS
| $16.8M | 0.02% |
1,164,095
+163,202
| +16% | +$3.16M |
|
986
Open Text
OTEX
$6.38B
| $16.8M | 0.02% |
482,756
+375,966
| +352% | +$13.1M |
|
987
Vanda Pharmaceuticals
VNDA
$313M
| $16.8M | 0.02% |
996,275
-131,290
| -12% | -$2.2M |
|
988
Insperity
NSP
$2.05B
| $16.8M | 0.02% |
240,847
+106,443
| +79% | +$6.8M |
|
989
PUT
CSX Corp
CSX
$92.1B
| $16.7M | 0.02% |
+900,000
| New | +$16.8M |
|
990
Inogen
INGN
$183M
| $16.7M | 0.02% |
135,994
-135,934
| -50% | -$16.6M |
|
991
Korn Ferry
KFY
$4.23B
| $16.7M | 0.02% |
323,724
-165,215
| -34% | -$7.35M |
|
992
OSI Systems
OSIS
$3.7B
| $16.7M | 0.02% |
255,483
-170,680
| -40% | -$11.1M |
|
993
Arbor Realty Trust
ABR
$983M
| $16.6M | 0.02% |
1,887,718
+242,154
| +15% | +$2.06M |
|
|
CIT
994
DELISTED
CIT Group Inc.
CIT
| $16.6M | 0.02% |
323,288
+169,822
| +111% | +$8.92M |
|
995
Expeditors International
EXPD
$22.2B
| $16.6M | 0.02% |
262,610
+146,339
| +126% | +$9.41M |
|
|
ADAP
996
DELISTED
Adaptimmune Therapeutics
ADAP
| $16.6M | 0.02% |
1,477,641
+672,046
| +83% | +$5.88M |
|
|
PRTY
997
DELISTED
Party City Holdco Inc.
PRTY
| $16.5M | 0.02% |
1,060,473
+833,855
| +368% | +$12.6M |
|
998
Nice
NICE
$5.91B
| $16.5M | 0.02% |
175,701
+159,773
| +1,003% | +$14.9M |
|
999
Rithm Capital
RITM
$5.62B
| $16.3M | 0.02% |
993,299
-1,352,922
| -58% | -$23M |
|
1000
Sixth Street Specialty
TSLX
$1.69B
| $16.3M | 0.02% |
911,471
+277,757
| +44% | +$5.21M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.